Thermodynamic phase behaviour of indomethacin/PLGA formulations
Display Omitted
Autor*in: |
Prudic, Anke [verfasserIn] |
---|
Format: |
E-Artikel |
---|---|
Sprache: |
Englisch |
Erschienen: |
2015 |
---|
Schlagwörter: |
---|
Umfang: |
7 |
---|
Übergeordnetes Werk: |
Enthalten in: Combat periarticular tibia injury outcome study (CAPTIOUS): risk factors for reoperation and amputation after open periarticular tibia fractures - Fleming, Mark E. ELSEVIER, 2015, EJPB : official journal of the International Association for Pharmaceutical Technology, New York, NY [u.a.] |
---|---|
Übergeordnetes Werk: |
volume:93 ; year:2015 ; pages:88-94 ; extent:7 |
Links: |
---|
DOI / URN: |
10.1016/j.ejpb.2015.01.029 |
---|
Katalog-ID: |
ELV02376726X |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | ELV02376726X | ||
003 | DE-627 | ||
005 | 20230623171451.0 | ||
007 | cr uuu---uuuuu | ||
008 | 180603s2015 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.ejpb.2015.01.029 |2 doi | |
028 | 5 | 2 | |a GBVA2015014000015.pica |
035 | |a (DE-627)ELV02376726X | ||
035 | |a (ELSEVIER)S0939-6411(15)00045-4 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
082 | 0 | |a 610 | |
082 | 0 | 4 | |a 610 |q DE-600 |
082 | 0 | 4 | |a 610 |q VZ |
082 | 0 | 4 | |a 540 |a 530 |q VZ |
084 | |a ASIEN |q DE-1a |2 fid | ||
084 | |a 6,25 |2 ssgn | ||
084 | |a 35.90 |2 bkl | ||
084 | |a 33.61 |2 bkl | ||
084 | |a 51.00 |2 bkl | ||
100 | 1 | |a Prudic, Anke |e verfasserin |4 aut | |
245 | 1 | 0 | |a Thermodynamic phase behaviour of indomethacin/PLGA formulations |
264 | 1 | |c 2015 | |
300 | |a 7 | ||
336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
337 | |a nicht spezifiziert |b z |2 rdamedia | ||
338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
520 | |a Display Omitted | ||
650 | 7 | |a Poorly soluble pharmaceutical |2 Elsevier | |
650 | 7 | |a PLGA |2 Elsevier | |
650 | 7 | |a Thermodynamic model |2 Elsevier | |
650 | 7 | |a Phase behaviour |2 Elsevier | |
650 | 7 | |a Kwei-equation |2 Elsevier | |
650 | 7 | |a Indomethacin |2 Elsevier | |
650 | 7 | |a Copolymer |2 Elsevier | |
650 | 7 | |a PC-SAFT |2 Elsevier | |
700 | 1 | |a Lesniak, Anna-Katharina |4 oth | |
700 | 1 | |a Ji, Yuanhui |4 oth | |
700 | 1 | |a Sadowski, Gabriele |4 oth | |
773 | 0 | 8 | |i Enthalten in |n Elsevier |a Fleming, Mark E. ELSEVIER |t Combat periarticular tibia injury outcome study (CAPTIOUS): risk factors for reoperation and amputation after open periarticular tibia fractures |d 2015 |d EJPB : official journal of the International Association for Pharmaceutical Technology |g New York, NY [u.a.] |w (DE-627)ELV013352458 |
773 | 1 | 8 | |g volume:93 |g year:2015 |g pages:88-94 |g extent:7 |
856 | 4 | 0 | |u https://doi.org/10.1016/j.ejpb.2015.01.029 |3 Volltext |
912 | |a GBV_USEFLAG_U | ||
912 | |a GBV_ELV | ||
912 | |a SYSFLAG_U | ||
912 | |a FID-ASIEN | ||
912 | |a SSG-OLC-PHA | ||
912 | |a GBV_ILN_40 | ||
936 | b | k | |a 35.90 |j Festkörperchemie |q VZ |
936 | b | k | |a 33.61 |j Festkörperphysik |q VZ |
936 | b | k | |a 51.00 |j Werkstoffkunde: Allgemeines |q VZ |
951 | |a AR | ||
952 | |d 93 |j 2015 |h 88-94 |g 7 | ||
953 | |2 045F |a 610 |
author_variant |
a p ap |
---|---|
matchkey_str |
prudicankelesniakannakatharinajiyuanhuis:2015----:hroyaipaeeaiuoidmtaip |
hierarchy_sort_str |
2015 |
bklnumber |
35.90 33.61 51.00 |
publishDate |
2015 |
allfields |
10.1016/j.ejpb.2015.01.029 doi GBVA2015014000015.pica (DE-627)ELV02376726X (ELSEVIER)S0939-6411(15)00045-4 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 540 530 VZ ASIEN DE-1a fid 6,25 ssgn 35.90 bkl 33.61 bkl 51.00 bkl Prudic, Anke verfasserin aut Thermodynamic phase behaviour of indomethacin/PLGA formulations 2015 7 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Display Omitted Poorly soluble pharmaceutical Elsevier PLGA Elsevier Thermodynamic model Elsevier Phase behaviour Elsevier Kwei-equation Elsevier Indomethacin Elsevier Copolymer Elsevier PC-SAFT Elsevier Lesniak, Anna-Katharina oth Ji, Yuanhui oth Sadowski, Gabriele oth Enthalten in Elsevier Fleming, Mark E. ELSEVIER Combat periarticular tibia injury outcome study (CAPTIOUS): risk factors for reoperation and amputation after open periarticular tibia fractures 2015 EJPB : official journal of the International Association for Pharmaceutical Technology New York, NY [u.a.] (DE-627)ELV013352458 volume:93 year:2015 pages:88-94 extent:7 https://doi.org/10.1016/j.ejpb.2015.01.029 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-ASIEN SSG-OLC-PHA GBV_ILN_40 35.90 Festkörperchemie VZ 33.61 Festkörperphysik VZ 51.00 Werkstoffkunde: Allgemeines VZ AR 93 2015 88-94 7 045F 610 |
spelling |
10.1016/j.ejpb.2015.01.029 doi GBVA2015014000015.pica (DE-627)ELV02376726X (ELSEVIER)S0939-6411(15)00045-4 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 540 530 VZ ASIEN DE-1a fid 6,25 ssgn 35.90 bkl 33.61 bkl 51.00 bkl Prudic, Anke verfasserin aut Thermodynamic phase behaviour of indomethacin/PLGA formulations 2015 7 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Display Omitted Poorly soluble pharmaceutical Elsevier PLGA Elsevier Thermodynamic model Elsevier Phase behaviour Elsevier Kwei-equation Elsevier Indomethacin Elsevier Copolymer Elsevier PC-SAFT Elsevier Lesniak, Anna-Katharina oth Ji, Yuanhui oth Sadowski, Gabriele oth Enthalten in Elsevier Fleming, Mark E. ELSEVIER Combat periarticular tibia injury outcome study (CAPTIOUS): risk factors for reoperation and amputation after open periarticular tibia fractures 2015 EJPB : official journal of the International Association for Pharmaceutical Technology New York, NY [u.a.] (DE-627)ELV013352458 volume:93 year:2015 pages:88-94 extent:7 https://doi.org/10.1016/j.ejpb.2015.01.029 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-ASIEN SSG-OLC-PHA GBV_ILN_40 35.90 Festkörperchemie VZ 33.61 Festkörperphysik VZ 51.00 Werkstoffkunde: Allgemeines VZ AR 93 2015 88-94 7 045F 610 |
allfields_unstemmed |
10.1016/j.ejpb.2015.01.029 doi GBVA2015014000015.pica (DE-627)ELV02376726X (ELSEVIER)S0939-6411(15)00045-4 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 540 530 VZ ASIEN DE-1a fid 6,25 ssgn 35.90 bkl 33.61 bkl 51.00 bkl Prudic, Anke verfasserin aut Thermodynamic phase behaviour of indomethacin/PLGA formulations 2015 7 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Display Omitted Poorly soluble pharmaceutical Elsevier PLGA Elsevier Thermodynamic model Elsevier Phase behaviour Elsevier Kwei-equation Elsevier Indomethacin Elsevier Copolymer Elsevier PC-SAFT Elsevier Lesniak, Anna-Katharina oth Ji, Yuanhui oth Sadowski, Gabriele oth Enthalten in Elsevier Fleming, Mark E. ELSEVIER Combat periarticular tibia injury outcome study (CAPTIOUS): risk factors for reoperation and amputation after open periarticular tibia fractures 2015 EJPB : official journal of the International Association for Pharmaceutical Technology New York, NY [u.a.] (DE-627)ELV013352458 volume:93 year:2015 pages:88-94 extent:7 https://doi.org/10.1016/j.ejpb.2015.01.029 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-ASIEN SSG-OLC-PHA GBV_ILN_40 35.90 Festkörperchemie VZ 33.61 Festkörperphysik VZ 51.00 Werkstoffkunde: Allgemeines VZ AR 93 2015 88-94 7 045F 610 |
allfieldsGer |
10.1016/j.ejpb.2015.01.029 doi GBVA2015014000015.pica (DE-627)ELV02376726X (ELSEVIER)S0939-6411(15)00045-4 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 540 530 VZ ASIEN DE-1a fid 6,25 ssgn 35.90 bkl 33.61 bkl 51.00 bkl Prudic, Anke verfasserin aut Thermodynamic phase behaviour of indomethacin/PLGA formulations 2015 7 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Display Omitted Poorly soluble pharmaceutical Elsevier PLGA Elsevier Thermodynamic model Elsevier Phase behaviour Elsevier Kwei-equation Elsevier Indomethacin Elsevier Copolymer Elsevier PC-SAFT Elsevier Lesniak, Anna-Katharina oth Ji, Yuanhui oth Sadowski, Gabriele oth Enthalten in Elsevier Fleming, Mark E. ELSEVIER Combat periarticular tibia injury outcome study (CAPTIOUS): risk factors for reoperation and amputation after open periarticular tibia fractures 2015 EJPB : official journal of the International Association for Pharmaceutical Technology New York, NY [u.a.] (DE-627)ELV013352458 volume:93 year:2015 pages:88-94 extent:7 https://doi.org/10.1016/j.ejpb.2015.01.029 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-ASIEN SSG-OLC-PHA GBV_ILN_40 35.90 Festkörperchemie VZ 33.61 Festkörperphysik VZ 51.00 Werkstoffkunde: Allgemeines VZ AR 93 2015 88-94 7 045F 610 |
allfieldsSound |
10.1016/j.ejpb.2015.01.029 doi GBVA2015014000015.pica (DE-627)ELV02376726X (ELSEVIER)S0939-6411(15)00045-4 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 540 530 VZ ASIEN DE-1a fid 6,25 ssgn 35.90 bkl 33.61 bkl 51.00 bkl Prudic, Anke verfasserin aut Thermodynamic phase behaviour of indomethacin/PLGA formulations 2015 7 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Display Omitted Poorly soluble pharmaceutical Elsevier PLGA Elsevier Thermodynamic model Elsevier Phase behaviour Elsevier Kwei-equation Elsevier Indomethacin Elsevier Copolymer Elsevier PC-SAFT Elsevier Lesniak, Anna-Katharina oth Ji, Yuanhui oth Sadowski, Gabriele oth Enthalten in Elsevier Fleming, Mark E. ELSEVIER Combat periarticular tibia injury outcome study (CAPTIOUS): risk factors for reoperation and amputation after open periarticular tibia fractures 2015 EJPB : official journal of the International Association for Pharmaceutical Technology New York, NY [u.a.] (DE-627)ELV013352458 volume:93 year:2015 pages:88-94 extent:7 https://doi.org/10.1016/j.ejpb.2015.01.029 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-ASIEN SSG-OLC-PHA GBV_ILN_40 35.90 Festkörperchemie VZ 33.61 Festkörperphysik VZ 51.00 Werkstoffkunde: Allgemeines VZ AR 93 2015 88-94 7 045F 610 |
language |
English |
source |
Enthalten in Combat periarticular tibia injury outcome study (CAPTIOUS): risk factors for reoperation and amputation after open periarticular tibia fractures New York, NY [u.a.] volume:93 year:2015 pages:88-94 extent:7 |
sourceStr |
Enthalten in Combat periarticular tibia injury outcome study (CAPTIOUS): risk factors for reoperation and amputation after open periarticular tibia fractures New York, NY [u.a.] volume:93 year:2015 pages:88-94 extent:7 |
format_phy_str_mv |
Article |
bklname |
Festkörperchemie Festkörperphysik Werkstoffkunde: Allgemeines |
institution |
findex.gbv.de |
topic_facet |
Poorly soluble pharmaceutical PLGA Thermodynamic model Phase behaviour Kwei-equation Indomethacin Copolymer PC-SAFT |
dewey-raw |
610 |
isfreeaccess_bool |
false |
container_title |
Combat periarticular tibia injury outcome study (CAPTIOUS): risk factors for reoperation and amputation after open periarticular tibia fractures |
authorswithroles_txt_mv |
Prudic, Anke @@aut@@ Lesniak, Anna-Katharina @@oth@@ Ji, Yuanhui @@oth@@ Sadowski, Gabriele @@oth@@ |
publishDateDaySort_date |
2015-01-01T00:00:00Z |
hierarchy_top_id |
ELV013352458 |
dewey-sort |
3610 |
id |
ELV02376726X |
language_de |
englisch |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV02376726X</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230623171451.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180603s2015 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.ejpb.2015.01.029</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2015014000015.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV02376726X</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0939-6411(15)00045-4</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">540</subfield><subfield code="a">530</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">ASIEN</subfield><subfield code="q">DE-1a</subfield><subfield code="2">fid</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">6,25</subfield><subfield code="2">ssgn</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">35.90</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">33.61</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">51.00</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Prudic, Anke</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Thermodynamic phase behaviour of indomethacin/PLGA formulations</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2015</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">7</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Display Omitted</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Poorly soluble pharmaceutical</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">PLGA</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Thermodynamic model</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Phase behaviour</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Kwei-equation</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Indomethacin</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Copolymer</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">PC-SAFT</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Lesniak, Anna-Katharina</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ji, Yuanhui</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Sadowski, Gabriele</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier</subfield><subfield code="a">Fleming, Mark E. ELSEVIER</subfield><subfield code="t">Combat periarticular tibia injury outcome study (CAPTIOUS): risk factors for reoperation and amputation after open periarticular tibia fractures</subfield><subfield code="d">2015</subfield><subfield code="d">EJPB : official journal of the International Association for Pharmaceutical Technology</subfield><subfield code="g">New York, NY [u.a.]</subfield><subfield code="w">(DE-627)ELV013352458</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:93</subfield><subfield code="g">year:2015</subfield><subfield code="g">pages:88-94</subfield><subfield code="g">extent:7</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.ejpb.2015.01.029</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">FID-ASIEN</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">35.90</subfield><subfield code="j">Festkörperchemie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">33.61</subfield><subfield code="j">Festkörperphysik</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">51.00</subfield><subfield code="j">Werkstoffkunde: Allgemeines</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">93</subfield><subfield code="j">2015</subfield><subfield code="h">88-94</subfield><subfield code="g">7</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
author |
Prudic, Anke |
spellingShingle |
Prudic, Anke ddc 610 ddc 540 fid ASIEN ssgn 6,25 bkl 35.90 bkl 33.61 bkl 51.00 Elsevier Poorly soluble pharmaceutical Elsevier PLGA Elsevier Thermodynamic model Elsevier Phase behaviour Elsevier Kwei-equation Elsevier Indomethacin Elsevier Copolymer Elsevier PC-SAFT Thermodynamic phase behaviour of indomethacin/PLGA formulations |
authorStr |
Prudic, Anke |
ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV013352458 |
format |
electronic Article |
dewey-ones |
610 - Medicine & health 540 - Chemistry & allied sciences 530 - Physics |
delete_txt_mv |
keep |
author_role |
aut |
collection |
elsevier |
remote_str |
true |
illustrated |
Not Illustrated |
topic_title |
610 610 DE-600 610 VZ 540 530 VZ ASIEN DE-1a fid 6,25 ssgn 35.90 bkl 33.61 bkl 51.00 bkl Thermodynamic phase behaviour of indomethacin/PLGA formulations Poorly soluble pharmaceutical Elsevier PLGA Elsevier Thermodynamic model Elsevier Phase behaviour Elsevier Kwei-equation Elsevier Indomethacin Elsevier Copolymer Elsevier PC-SAFT Elsevier |
topic |
ddc 610 ddc 540 fid ASIEN ssgn 6,25 bkl 35.90 bkl 33.61 bkl 51.00 Elsevier Poorly soluble pharmaceutical Elsevier PLGA Elsevier Thermodynamic model Elsevier Phase behaviour Elsevier Kwei-equation Elsevier Indomethacin Elsevier Copolymer Elsevier PC-SAFT |
topic_unstemmed |
ddc 610 ddc 540 fid ASIEN ssgn 6,25 bkl 35.90 bkl 33.61 bkl 51.00 Elsevier Poorly soluble pharmaceutical Elsevier PLGA Elsevier Thermodynamic model Elsevier Phase behaviour Elsevier Kwei-equation Elsevier Indomethacin Elsevier Copolymer Elsevier PC-SAFT |
topic_browse |
ddc 610 ddc 540 fid ASIEN ssgn 6,25 bkl 35.90 bkl 33.61 bkl 51.00 Elsevier Poorly soluble pharmaceutical Elsevier PLGA Elsevier Thermodynamic model Elsevier Phase behaviour Elsevier Kwei-equation Elsevier Indomethacin Elsevier Copolymer Elsevier PC-SAFT |
format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
format_main_str_mv |
Text Zeitschrift/Artikel |
carriertype_str_mv |
zu |
author2_variant |
a k l akl y j yj g s gs |
hierarchy_parent_title |
Combat periarticular tibia injury outcome study (CAPTIOUS): risk factors for reoperation and amputation after open periarticular tibia fractures |
hierarchy_parent_id |
ELV013352458 |
dewey-tens |
610 - Medicine & health 540 - Chemistry 530 - Physics |
hierarchy_top_title |
Combat periarticular tibia injury outcome study (CAPTIOUS): risk factors for reoperation and amputation after open periarticular tibia fractures |
isfreeaccess_txt |
false |
familylinks_str_mv |
(DE-627)ELV013352458 |
title |
Thermodynamic phase behaviour of indomethacin/PLGA formulations |
ctrlnum |
(DE-627)ELV02376726X (ELSEVIER)S0939-6411(15)00045-4 |
title_full |
Thermodynamic phase behaviour of indomethacin/PLGA formulations |
author_sort |
Prudic, Anke |
journal |
Combat periarticular tibia injury outcome study (CAPTIOUS): risk factors for reoperation and amputation after open periarticular tibia fractures |
journalStr |
Combat periarticular tibia injury outcome study (CAPTIOUS): risk factors for reoperation and amputation after open periarticular tibia fractures |
lang_code |
eng |
isOA_bool |
false |
dewey-hundreds |
600 - Technology 500 - Science |
recordtype |
marc |
publishDateSort |
2015 |
contenttype_str_mv |
zzz |
container_start_page |
88 |
author_browse |
Prudic, Anke |
container_volume |
93 |
physical |
7 |
class |
610 610 DE-600 610 VZ 540 530 VZ ASIEN DE-1a fid 6,25 ssgn 35.90 bkl 33.61 bkl 51.00 bkl |
format_se |
Elektronische Aufsätze |
author-letter |
Prudic, Anke |
doi_str_mv |
10.1016/j.ejpb.2015.01.029 |
dewey-full |
610 540 530 |
title_sort |
thermodynamic phase behaviour of indomethacin/plga formulations |
title_auth |
Thermodynamic phase behaviour of indomethacin/PLGA formulations |
abstract |
Display Omitted |
abstractGer |
Display Omitted |
abstract_unstemmed |
Display Omitted |
collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-ASIEN SSG-OLC-PHA GBV_ILN_40 |
title_short |
Thermodynamic phase behaviour of indomethacin/PLGA formulations |
url |
https://doi.org/10.1016/j.ejpb.2015.01.029 |
remote_bool |
true |
author2 |
Lesniak, Anna-Katharina Ji, Yuanhui Sadowski, Gabriele |
author2Str |
Lesniak, Anna-Katharina Ji, Yuanhui Sadowski, Gabriele |
ppnlink |
ELV013352458 |
mediatype_str_mv |
z |
isOA_txt |
false |
hochschulschrift_bool |
false |
author2_role |
oth oth oth |
doi_str |
10.1016/j.ejpb.2015.01.029 |
up_date |
2024-07-06T19:40:43.600Z |
_version_ |
1803859885924810752 |
fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV02376726X</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230623171451.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180603s2015 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.ejpb.2015.01.029</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2015014000015.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV02376726X</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0939-6411(15)00045-4</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">540</subfield><subfield code="a">530</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">ASIEN</subfield><subfield code="q">DE-1a</subfield><subfield code="2">fid</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">6,25</subfield><subfield code="2">ssgn</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">35.90</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">33.61</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">51.00</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Prudic, Anke</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Thermodynamic phase behaviour of indomethacin/PLGA formulations</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2015</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">7</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Display Omitted</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Poorly soluble pharmaceutical</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">PLGA</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Thermodynamic model</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Phase behaviour</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Kwei-equation</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Indomethacin</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Copolymer</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">PC-SAFT</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Lesniak, Anna-Katharina</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ji, Yuanhui</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Sadowski, Gabriele</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier</subfield><subfield code="a">Fleming, Mark E. ELSEVIER</subfield><subfield code="t">Combat periarticular tibia injury outcome study (CAPTIOUS): risk factors for reoperation and amputation after open periarticular tibia fractures</subfield><subfield code="d">2015</subfield><subfield code="d">EJPB : official journal of the International Association for Pharmaceutical Technology</subfield><subfield code="g">New York, NY [u.a.]</subfield><subfield code="w">(DE-627)ELV013352458</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:93</subfield><subfield code="g">year:2015</subfield><subfield code="g">pages:88-94</subfield><subfield code="g">extent:7</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.ejpb.2015.01.029</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">FID-ASIEN</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">35.90</subfield><subfield code="j">Festkörperchemie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">33.61</subfield><subfield code="j">Festkörperphysik</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">51.00</subfield><subfield code="j">Werkstoffkunde: Allgemeines</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">93</subfield><subfield code="j">2015</subfield><subfield code="h">88-94</subfield><subfield code="g">7</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
score |
7.4014616 |